PRISM II: An Open-Label Study to Assess the Safety, Tolerability, and Effectiveness of Dextromethorphan 20 mg/Quinidine 10 mg for Treatment of Pseudobulbar Affect Secondary to Dementia, Stroke, or Traumatic Brain Injury: Results from the Alzheimer's Disease/Dementia Cohort

被引：0
|
作者：
Doody, Rachelle S. [1 ]
D'Amico, Stephen [2 ]
Cutler, Andrew J. [3 ]
Shin, Paul [4 ]
Ledon, Frederic [4 ]
Yonan, Charles [4 ]
Siffert, Joao [4 ]
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
[2] Cornerstone Med Grp, Franklin, TN USA
[3] Florida Clin Res Ctr LLC, Bradenton, FL USA
[4] Avanir Pharmaceut Inc, Aliso Viejo, CA USA
来源：
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY | 2015年 / 23卷 / 03期
关键词：
D O I：
10.1016/j.jagp.2014.12.170
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
NR 17
引用
收藏
页码：S163 / S164
页数：3
相关论文
共 14 条
  • [1] PRISM II: Effectiveness of Dextromethorphan 20 mg/Quinidine 10 mg (NUEDEXTA®) for Treatment of Pseudobulbar Affect Secondary to Dementia, Stroke, or Traumatic Brain Injury: Combined Results of a Multicenter Open-Label Study
    Siffert, Joao
    Hammond, Flora
    Alexander, David
    Cutler, Andrew
    D'Amico, Stephen
    Doody, Rachelle
    Sauve, William
    Zorowitz, Richard
    Davis, Charles
    Shin, Paul
    Ledon, Fred
    Yonan, Charles
    Formella, Andrea
    NEUROLOGY, 2016, 86
  • [2] PRISM II: Effectiveness of Dextromethorphan 20 mg/Quinidine 10 mg (NUEDEXTA) for Treatment of Pseudobulbar Affect Secondary to Dementia, Stroke, or Traumatic Brain Injury: Combined Results of a Multicenter Open-label Study
    Hammond, Flora
    Siffert, Joao
    Alexander, David
    Cutler, Andrew J.
    D'Amico, Stephen
    Doody, Rachelle
    Formella, Andrea
    Ledon, Fred
    Sauve, William
    Shin, Paul
    Yonan, Charles
    Zorowitz, Richard
    NEUROPSYCHOPHARMACOLOGY, 2015, 40 : S365 - S366
  • [3] An open-label study to assess safety, tolerability, and effectiveness of dextromethorphan/quinidine for pseudobulbar affect in dementia: PRISM II results
    Doody, Rachelle S.
    D'Amico, Stephen
    Cutler, Andrew J.
    Davis, Charles S.
    Shin, Paul
    Ledon, Fred
    Yonan, Charles
    Siffert, Joao
    CNS SPECTRUMS, 2016, 21 (06) : 450 - 459
  • [4] PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury
    Flora M. Hammond
    David N. Alexander
    Andrew J. Cutler
    Stephen D’Amico
    Rachelle S. Doody
    William Sauve
    Richard D. Zorowitz
    Charles S. Davis
    Paul Shin
    Fred Ledon
    Charles Yonan
    Andrea E. Formella
    Joao Siffert
    BMC Neurology, 16
  • [5] PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury
    Hammond, Flora M.
    Alexander, David N.
    Cutler, Andrew J.
    D'Amico, Stephen
    Doody, Rachelle S.
    Sauve, William
    Zorowitz, Richard D.
    Davis, Charles S.
    Shin, Paul
    Ledon, Fred
    Yonan, Charles
    Formella, Andrea E.
    Siffert, Joao
    BMC NEUROLOGY, 2016, 16
  • [6] Erratum to: PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury
    Flora M. Hammond
    David N. Alexander
    Andrew J. Cutler
    Stephen D’Amico
    Rachelle S. Doody
    William Sauve
    Richard D. Zorowitz
    Charles S. Davis
    Paul Shin
    Fred Ledon
    Charles Yonan
    Andrea E. Formella
    Joao Siffert
    BMC Neurology, 16
  • [7] An Open-Label Study to Assess Safety, Tolerability, and Effectiveness of Dextromethorphan/Quinidine for Pseudobulbar Affect (PBA) in Dementia, Stroke and Traumatic Brain Injury: PRISM II Combined Cohort Results for Patients Aged ≥65 Years
    Hammond, Flora
    Alexander, David N.
    Cutler, Andrew J.
    D'Amico, Stephen
    Doody, Rachelle S.
    Sauve, William
    Zorowitz, Richard D.
    Davis, Charles S.
    Shin, Paul
    Ledon, Fred
    Yonan, Charles
    Formella, Andrea E.
    Siffert, Joao
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2016, 24 (03): : S146 - S147
  • [8] Dextromethorphan/Quinidine: Safety, Tolerability, and Effectiveness for Pseudobulbar Affect in Patients with Alzheimer's Disease/Dementia: PRISM-II-Dementia-Cohort Results
    Doody, R. S.
    D'Amico, S.
    Cutler, A. J.
    Shin, P.
    Ledon, E.
    Yonan, C.
    Siffert, J.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2015, 63 : S34 - S34
  • [9] PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury (vol 16, 89, 2016)
    Hammond, Flora M.
    Alexander, David N.
    Cutler, Andrew J.
    D'Amico, Stephen
    Doody, Rachelle S.
    Sauve, William
    Zorowitz, Richard D.
    Davis, Charles S.
    Shin, Paul
    Ledon, Fred
    Yonan, Charles
    Formella, Andrea E.
    Siffert, Joao
    BMC NEUROLOGY, 2016, 16
  • [10] Safety, Tolerability, and Effectiveness of Dextromethorphan/Quinidine for Pseudobulbar Affect in Patients with Alzheimer's Disease/Dementia: PRISM-II
    Doody, Rachelle S.
    D'Amico, Stephen
    Cutler, Andrew J.
    Shin, Paul
    Ledon, Fred
    Yonan, Charles
    Siffert, Joao
    ANNALS OF NEUROLOGY, 2014, 76 : S99 - S100
12